BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22942738)

  • 21. Expression of membrane-bound and soluble FasL in Fas- and FADD-dependent T lymphocyte apoptosis induced by mildly oxidized LDL.
    Alcouffe J; Therville N; Ségui B; Nazzal D; Blaes N; Salvayre R; Thomsen M; Benoist H
    FASEB J; 2004 Jan; 18(1):122-4. PubMed ID: 14630709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of nitric oxide synthase activity in phagocytic cells inhibited by tricyclodecan-9-yl-xanthogenate (D609).
    Tschaikowsky K; Meisner M; Schönhuber F; Rügheimer E
    Br J Pharmacol; 1994 Nov; 113(3):664-8. PubMed ID: 7532078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphatidylcholine-specific phospholipase C inhibitor, tricyclodecan-9-yl xanthogenate (D609), increases phospholipase D-mediated phosphatidylcholine hydrolysis in UMR-106 osteoblastic osteosarcoma cells.
    Singh AT; Radeff JM; Kunnel JG; Stern PH
    Biochim Biophys Acta; 2000 Sep; 1487(2-3):201-8. PubMed ID: 11018472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Helenalin triggers a CD95 death receptor-independent apoptosis that is not affected by overexpression of Bcl-x(L) or Bcl-2.
    Dirsch VM; Stuppner H; Vollmar AM
    Cancer Res; 2001 Aug; 61(15):5817-23. PubMed ID: 11479221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulation of DNA synthesis in untransformed cells by the antiviral and antitumoral compound tricyclodecan-9-yl-xanthogenate (D609).
    Kiss Z; Crilly KS; Chung T
    Biochem Pharmacol; 1998 Mar; 55(6):915-8. PubMed ID: 9586966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of human T cell proliferation by the caspase inhibitors, z-VAD-FMK and z-IETD-FMK is independent of their caspase inhibition properties.
    Lawrence CP; Chow SC
    Toxicol Appl Pharmacol; 2012 Nov; 265(1):103-12. PubMed ID: 22982538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ceramide induces mitochondrial activation and apoptosis via a Bax-dependent pathway in human carcinoma cells.
    von Haefen C; Wieder T; Gillissen B; Stärck L; Graupner V; Dörken B; Daniel PT
    Oncogene; 2002 Jun; 21(25):4009-19. PubMed ID: 12037683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C2-ceramide signaling in glioma cells: synergistic enhancement of CD95-mediated, caspase-dependent apoptosis.
    Wagenknecht B; Roth W; Gulbins E; Wolburg H; Weller M
    Cell Death Differ; 2001 Jun; 8(6):595-602. PubMed ID: 11536010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ceramide mediates FasL-induced caspase 8 activation in colon carcinoma cells to enhance FasL-induced cytotoxicity by tumor-specific cytotoxic T lymphocytes.
    Coe GL; Redd PS; Paschall AV; Lu C; Gu L; Cai H; Albers T; Lebedyeva IO; Liu K
    Sci Rep; 2016 Aug; 6():30816. PubMed ID: 27487939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Caspase inhibition in apoptotic T cells triggers necrotic cell death depending on the cell type and the proapoptotic stimulus.
    Scheller C; Knöferle J; Ullrich A; Prottengeier J; Racek T; Sopper S; Jassoy C; Rethwilm A; Koutsilieri E
    J Cell Biochem; 2006 Apr; 97(6):1350-61. PubMed ID: 16365881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitization to death receptor cytotoxicity by inhibition of fas-associated death domain protein (FADD)/caspase signaling. Requirement of cell cycle progression.
    Lüschen S; Ussat S; Scherer G; Kabelitz D; Adam-Klages S
    J Biol Chem; 2000 Aug; 275(32):24670-8. PubMed ID: 10827087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel role of the antitumor agent tricyclodecan-9-yl-xanthogenate as an open channel blocker of KCNQ1/KCNE1.
    Wu M; Takemoto M; Luo H; Xu JJ; Lu MH; Kameyama M; Takumi T; Song WJ
    Eur J Pharmacol; 2018 Apr; 824():99-107. PubMed ID: 29438706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. zVAD-fmk upregulates caspase-9 cleavage and activity in etoposide-induced cell death of mouse embryonic fibroblasts.
    Rodríguez-Enfedaque A; Delmas E; Guillaume A; Gaumer S; Mignotte B; Vayssière JL; Renaud F
    Biochim Biophys Acta; 2012 Aug; 1823(8):1343-52. PubMed ID: 22613767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of apoptosis and potentiation of TNF- and Fas-mediated apoptosis in U937 cells by the xanthogenate compound D609.
    Pörn-Ares MI; Chow SC; Slotte JP; Orrenius S
    Exp Cell Res; 1997 Aug; 235(1):48-54. PubMed ID: 9281351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of sphingomyelinase in mitochondrial ceramide accumulation during reperfusion.
    Ramírez-Camacho I; Bautista-Pérez R; Correa F; Buelna-Chontal M; Román-Anguiano NG; Medel-Franco M; Medina-Campos ON; Pedraza-Chaverri J; Cano-Martínez A; Zazueta C
    Biochim Biophys Acta; 2016 Oct; 1862(10):1955-63. PubMed ID: 27479697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. D609-mediated inhibition of ATP synthesis in neural progenitor cells.
    Kalluri HS; Dempsey RJ
    Neuroreport; 2014 Jul; 25(10):777-81. PubMed ID: 24918458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of sphingosine in mitochondria-dependent Fas-induced apoptosis of type II Jurkat T cells.
    Cuvillier O; Edsall L; Spiegel S
    J Biol Chem; 2000 May; 275(21):15691-700. PubMed ID: 10747891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ceramide generation occurring during 7beta-hydroxycholesterol- and 7-ketocholesterol-induced apoptosis is caspase independent and is not required to trigger cell death.
    Miguet C; Monier S; Bettaieb A; Athias A; Besséde G; Laubriet A; Lemaire S; Néel D; Gambert P; Lizard G
    Cell Death Differ; 2001 Jan; 8(1):83-99. PubMed ID: 11313706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ordering of ceramide formation and caspase-9 activation in CD95L-induced Jurkat leukemia T cell apoptosis.
    Lafont E; Dupont R; Andrieu-Abadie N; Okazaki T; Schulze-Osthoff K; Levade T; Benoist H; Ségui B
    Biochim Biophys Acta; 2012 Apr; 1821(4):684-93. PubMed ID: 22306364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prodrug modification increases potassium tricyclo[5.2.1.0(2,6)]-decan-8-yl dithiocarbonate (D609) chemical stability and cytotoxicity against U937 leukemia cells.
    Bai A; Meier GP; Wang Y; Luberto C; Hannun YA; Zhou D
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1051-9. PubMed ID: 14960662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.